These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 12237531)

  • 1. Design of controlled release system with multi-layers of powder.
    Shimono N; Ueda M; Nakamura Y
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1169-75. PubMed ID: 12237531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The coating and the encapsulation of an interactive powder mixture and its application to sustained release preparations.
    Yoshizawa H; Koishi M
    J Pharm Pharmacol; 1990 Oct; 42(10):673-8. PubMed ID: 1982136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release from or through a wax matrix system. IV. Generalized expression of the release process for a reservoir device tablet.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Sep; 50(9):1219-22. PubMed ID: 12237539
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral controlled release system for ambroxol hydrochloride containing a wax and a water insoluble polymer.
    Chi N; Guo JH; Zhang Y; Zhang W; Tang X
    Pharm Dev Technol; 2010; 15(1):97-104. PubMed ID: 19671037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine.
    Tanaka N; Imai K; Okimoto K; Ueda S; Tokunaga Y; Ohike A; Ibuki R; Higaki K; Kimura T
    J Control Release; 2005 Nov; 108(2-3):386-95. PubMed ID: 16253377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled drug release of highly water-soluble pentoxifylline from time-limit disintegration-type wax matrix tablets.
    Otsuka M; Matsuda Y
    Pharm Res; 1994 Mar; 11(3):351-4. PubMed ID: 8008697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of sustained-release lipophilic calcium stearate pellets via hot melt extrusion.
    Roblegg E; Jäger E; Hodzic A; Koscher G; Mohr S; Zimmer A; Khinast J
    Eur J Pharm Biopharm; 2011 Nov; 79(3):635-45. PubMed ID: 21801834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of acetaminophen capsules containing beads prepared by hot-melt direct blend coating.
    Pham L; Christensen JM
    Pharm Dev Technol; 2014 Feb; 19(1):91-102. PubMed ID: 23324019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of drug release from acetaminophen granules by melt granulation technique - consideration of release kinetics.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2006 Jan; 19(1):22-7. PubMed ID: 16632448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carnauba wax as a promising excipient in melt granulation targeting the preparation of mini-tablets for sustained release of highly soluble drugs.
    Nart V; Beringhs AO; França MT; de Espíndola B; Pezzini BR; Stulzer HK
    Mater Sci Eng C Mater Biol Appl; 2017 Jan; 70(Pt 1):250-257. PubMed ID: 27770888
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of processing methods and heat treatment on the formation of wax matrix tablets for sustained drug release.
    Zhang YE; Tchao R; Schwartz JB
    Pharm Dev Technol; 2001; 6(2):131-44. PubMed ID: 11416986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wax-based sustained release matrix pellets prepared by a novel freeze pelletization technique II. In vitro drug release studies and release mechanisms.
    Cheboyina S; Wyandt CM
    Int J Pharm; 2008 Jul; 359(1-2):167-73. PubMed ID: 18495391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipids bearing extruded-spheronized pellets for extended release of poorly soluble antiemetic agent-Meclizine HCl.
    Qazi F; Shoaib MH; Yousuf RI; Nasiri MI; Ahmed K; Ahmad M
    Lipids Health Dis; 2017 Apr; 16(1):75. PubMed ID: 28403892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of lipid and cellulose based matrix former on the release of highly soluble drug from extruded/spheronized, sintered and compacted pellets.
    Maboos M; Yousuf RI; Shoaib MH; Nasiri I; Hussain T; Ahmed HF; Iffat W
    Lipids Health Dis; 2018 Jun; 17(1):136. PubMed ID: 29885655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pH Modulation on Dynamic Behavior of Gel Layer and Release of Weakly Basic Drug from HPMC/Wax Matrices, Controlled by Acidic Modifiers Evaluated by Multivariate Data Analysis.
    Mašková E; Kubová K; Vysloužil J; Pavloková S; Vetchý D
    AAPS PharmSciTech; 2017 May; 18(4):1242-1253. PubMed ID: 27474035
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Applying a novel electrostatic dry powder coating technology to pellets.
    Yang Q; Ma Y; Zhu J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):118-24. PubMed ID: 26478275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release from or through a wax matrix system. II. Basic properties of release from or through the wax matrix layer.
    Yonezawa Y; Ishida S; Suzuki S; Sunada H
    Chem Pharm Bull (Tokyo); 2002 Feb; 50(2):220-4. PubMed ID: 11848213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-unit dosage formulations of theophylline for controlled release applications.
    Uhumwangho MU; Okor RS
    Acta Pol Pharm; 2007; 64(6):553-9. PubMed ID: 18323251
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Release from or through a wax matrix system. I. Basic release properties of the wax matrix system.
    Yonezawa Y; Ishida S; Sunada H
    Chem Pharm Bull (Tokyo); 2001 Nov; 49(11):1448-51. PubMed ID: 11724236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sintering of wax for controlling release from pellets.
    Singh R; Poddar SS; Chivate A
    AAPS PharmSciTech; 2007 Sep; 8(3):E74. PubMed ID: 17915824
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.